Critically analyzing clinical data: post-hoc analysis of aducanumab

  Рет қаралды 2,362

Bay Bridge Bio

Bay Bridge Bio

Күн бұрын

Пікірлер: 3
@vasiliikacman6005
@vasiliikacman6005 6 ай бұрын
Such a great videos! Thank you so much for sharing your knowledge! Hope you will not abandon this channel
@bioflamingo1248
@bioflamingo1248 2 жыл бұрын
Thank you for your videos, always really clear and interesting. Keep it up!
@uauu9099
@uauu9099 2 жыл бұрын
Thank you. Very useful
Intro to FDA Advisory Committee meetings: aducanumab's AdComm
17:02
Intro to FDA Advisory Committee meetings: aducanumab's AdComm
Bay Bridge Bio
Рет қаралды 1,5 М.
Analyzing the clinical data for Aduhelm, Biogen's controversial Alzheimer's drug
19:46
Analyzing the clinical data for Aduhelm, Biogen's controversial Alzheimer's drug
Bay Bridge Bio
Рет қаралды 2,8 М.
Walking on LEGO Be Like... #shorts #mingweirocks
00:41
Walking on LEGO Be Like... #shorts #mingweirocks
mingweirocks
Рет қаралды 6 МЛН
The Joker and the Angel fell into the hole, but luckily Harley Quinn rescued them #Angel
00:20
The Joker and the Angel fell into the hole, but luckily Harley Quinn rescued them #Angel
超人夫妇
Рет қаралды 97 МЛН
Now you won't have problems💡🧼#camping #survival #bushcraft #outdoors #lifehack
00:21
Now you won't have problems💡🧼#camping #survival #bushcraft #outdoors #lifehack
Marusya Outdoors
Рет қаралды 45 МЛН
Не так важно как ТЫ БЬЁШЬ, а важно какой ДЕРЖИШЬ УДАР😎 #shorts
01:00
Не так важно как ТЫ БЬЁШЬ, а важно какой ДЕРЖИШЬ УДАР😎 #shorts
BalcevMMA_BOXING
Рет қаралды 13 МЛН
Bargain hunting for biotech stocks
28:41
Bargain hunting for biotech stocks
Bay Bridge Bio
Рет қаралды 10 М.
Analyzing FDA Ad Comm minutes: was the aducanumab Ad Comm biased?
25:20
Analyzing FDA Ad Comm minutes: was the aducanumab Ad Comm biased?
Bay Bridge Bio
Рет қаралды 1 М.
Analyzing biotech clinical trial risk: Frank David, founder of Pharmagellan
42:50
Analyzing biotech clinical trial risk: Frank David, founder of Pharmagellan
Bay Bridge Bio
Рет қаралды 5 М.
Why short selling biotech stocks is dangerous
19:00
Why short selling biotech stocks is dangerous
Bay Bridge Bio
Рет қаралды 4 М.
Intro to clinical data: biotech investing basics
25:25
Intro to clinical data: biotech investing basics
Bay Bridge Bio
Рет қаралды 4,6 М.
Analyzing FDA's statistical review of a Phase 3 program
25:59
Analyzing FDA's statistical review of a Phase 3 program
Bay Bridge Bio
Рет қаралды 1,1 М.
Case study in analyzing biotech clinical trial risk
33:22
Case study in analyzing biotech clinical trial risk
Bay Bridge Bio
Рет қаралды 2,6 М.
Biotech investing basics part 4: DCF analysis
46:02
Biotech investing basics part 4: DCF analysis
Bay Bridge Bio
Рет қаралды 14 М.
Leaving your job to start a biotech company: interview with Geoff Harris, CEO of Ocelot Bio
45:34
Leaving your job to start a biotech company: interview with Geoff Harris, CEO of Ocelot Bio
Bay Bridge Bio
Рет қаралды 1,9 М.
The biotech venture capital crunch
17:11
The biotech venture capital crunch
Bay Bridge Bio
Рет қаралды 4,5 М.
Walking on LEGO Be Like... #shorts #mingweirocks
00:41
Walking on LEGO Be Like... #shorts #mingweirocks
mingweirocks
Рет қаралды 6 МЛН